Litigation against Zantac manufacturers filed in the state of New York will move forward as a consolidated action, a panel has ruled.
The New York State Litigation Coordinating Panel on Thursday combined some 40 active cases for pre-trial litigation in New York County. Any future ranitidine-related personal injury cases filed in the state will proceed under this same action, the ruling said.
